Connection
Hakan Paydak to Anticoagulants
This is a "connection" page, showing publications Hakan Paydak has written about Anticoagulants.
|
|
Connection Strength |
|
|
|
|
|
0.839 |
|
|
|
-
Nairooz R, Sardar P, Payne J, Aronow WS, Paydak H. Meta-analysis of major bleeding with uninterrupted warfarin compared to interrupted warfarin and heparin bridging in ablation of atrial fibrillation. Int J Cardiol. 2015; 187:426-9.
Score: 0.407
-
Kattoor AJ, Pothineni NV, Goel A, Syed M, Syed S, Paydak H, Mehta JL. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis. J Cardiovasc Pharmacol Ther. 2019 09; 24(5):428-434.
Score: 0.135
-
Ayoub K, Nairooz R, Almomani A, Marji M, Paydak H, Maskoun W. Perioperative Heparin Bridging in Atrial Fibrillation Patients Requiring Temporary Interruption of Anticoagulation: Evidence from Meta-analysis. J Stroke Cerebrovasc Dis. 2016 Sep; 25(9):2215-21.
Score: 0.111
-
Nairooz R, Sardar P, Pino M, Aronow WS, Sewani A, Mukherjee D, Paydak H, Maskoun W. Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation. Int J Cardiol. 2015; 187:345-53.
Score: 0.102
-
Deshmukh A, Pothineni NV, Pant S, Paydak H. Pacemaker lead malposition: When right is not right! Arch Cardiovasc Dis. 2014 Mar; 107(3):201-2.
Score: 0.084
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|